1. Home
  2. PTY vs WGS Comparison

PTY vs WGS Comparison

Compare PTY & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pimco Corporate & Income Opportunity Fund

PTY

Pimco Corporate & Income Opportunity Fund

N/A

Current Price

$11.01

Market Cap

2.4B

Sector

Finance

ML Signal

N/A

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

N/A

Current Price

$70.96

Market Cap

2.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
PTY
WGS
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.7B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
PTY
WGS
Price
$11.01
$70.96
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $90.44
AVG Volume (30 Days)
★ 1.7M
645.5K
Earning Date
01-01-0001
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 62.37
EPS
★ N/A
N/A
Revenue
N/A
★ $427,539,000.00
Revenue This Year
N/A
$12.70
Revenue Next Year
N/A
$24.31
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 39.97
52 Week Low
$10.65
$32.21
52 Week High
$14.69
$170.87

Technical Indicators

Market Signals
Indicator
PTY
WGS
Relative Strength Index (RSI) 37.74 36.98
Support Level N/A $71.85
Resistance Level $11.92 $94.82
Average True Range (ATR) 0.20 6.64
MACD -0.02 -3.00
Stochastic Oscillator 38.79 4.57

Price Performance

Historical Comparison
PTY
WGS

About PTY Pimco Corporate & Income Opportunity Fund

PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on both public or private basis.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: